Both in vitro and in vivo studies showed that when Tfeb was transferred into cells or PI-Z mutant mice it significantly reduced PI-Z accumulation, and reduced liver disease and fibrosis in vivo. The gene discussed is SERPINA1; the disease is liver disorder.